Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations

Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations

Pietro Castellan,1 Michele Marchioni,2 Roberto Castellucci,1 Piergustavo De Francesco,2 Romina Iantorno,1 Luigi Schips,1,2 Luca Cindolo1 1Department of Urology, ASL02 Abruzzo, Chieti, Italy; 2Department of Urology, University “G. d’Annunzio”, Chieti, Italy Abstract: In...

Full description

Bibliographic Details
Main Authors: Castellan P, Marchioni M, Castellucci R, De Francesco P, Iantorno R, Schips L, Cindolo L
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Therapeutics and Clinical Risk Management
Subjects:
prostate cancer
metastatic hormone-sensitive prostate cancer
androgen receptor
hormonal therapy
abiraterone acetate
prostate castration naïve.
Online Access:https://www.dovepress.com/abiraterone-acetate-for-early-stage-metastatic-prostate-cancer-patient-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/abiraterone-acetate-for-early-stage-metastatic-prostate-cancer-patient-peer-reviewed-article-TCRM

Similar Items